Design of Chimeric Histone Deacetylase-and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF- …
S Mahboobi, S Dove, A Sellmer, M Winkler…
Index: Mahboobi, Siavosh; Dove, Stefan; Sellmer, Andreas; Winkler, Matthias; Eichhorn, Emerich; Pongratz, Herwig; Ciossek, Thomas; Baer, Thomas; Maier, Thomas; Beckers, Thomas Journal of Medicinal Chemistry, 2009 , vol. 52, # 8 p. 2265 - 2279
Full Text: HTML
Citation Number: 58
Abstract
Inhibitors of histone deacetylases are a new class of cancer therapeutics with possibly broad applicability. Combinations of HDAC inhibitors with the kinase inhibitor 1 (Imatinib) in recent studies showed additive and synergistic effects. Here we present a new concept by combining inhibition of protein kinases and HDACs, two independent pharmacological activities, in one synthetic small molecule. In general, the HDAC inhibition profile, the ...
Related Articles:
Functionalized tetradentate ligands for Ru-sensitized solar cells
[Renouard, Thierry; Graetzel, Michael Tetrahedron, 2001 , vol. 57, # 38 p. 8145 - 8150]
[Carpenter, Andrew J,; Chadwick, Derek J. Tetrahedron, 1985 , vol. 41, # 18 p. 3803 - 3812]